Anti-TNF and IBD: bibliography

被引：0
|
作者：
Roblin, X. [1 ]
机构：
[1] Ctr Hosp Albert Michallon, Hospitalisat A, Dept Hepatogastroenterol, F-38043 Grenoble, France
来源：
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2008年 / 32卷 / 05期
关键词：
D O I：
10.1016/j.gcb.2008.03.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：482 / 485
页数：4
相关论文
共 50 条
  • [41] Is There an Increased Risk of Lymphoma and Malignancies Under Anti-TNF Therapy in IBD?
    Lakatos, P. L.
    Miheller, P.
    CURRENT DRUG TARGETS, 2010, 11 (02) : 179 - 186
  • [42] Management of psoriatic lesions associated with anti-TNF therapy in patients with IBD
    Rafael Denadai
    Fábio V. Teixeira
    Rogério Saad-Hossne
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 744 - 744
  • [43] Switching out of class or to another anti-TNF agent is the most effective strategy in IBD patients with immunogenicity against anti-TNF antibodies
    Anjie, S.
    Hanzel, J.
    Gecse, K. B.
    D'Haens, G. R.
    Brandse, J. F.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 803 - 803
  • [44] SERUM BILE ACIDS PROFILING IN IBD PATIENTS TREATED WITH ANTI-TNF
    Roda, Giulia
    Porru, Emanule
    Katsanos, Konstantinos
    Skamnelos, Alexandros
    Kyriakidi, Kallirroi
    Christodoulou, Dimitrios
    Caliceti, Cristiana
    Fiorino, Gionata
    Danese, Silvio
    Roda, Aldo
    GASTROENTEROLOGY, 2019, 156 (06) : S883 - S883
  • [45] Anti-TNF Therapy in Elderly People in IBD: An Italian Multicentre Survey
    Cottone, Mario
    Kohn, Anna
    Daperno, Marco
    Armuzzi, Alessandro
    Guidi, Luisa
    D'Inca, Renata
    Bossa, Fabrizio
    Biancone, Livia
    Gionchetti, Paolo
    Ardizzone, Sandro
    Papi, Claudio
    Fries, Walter
    Danese, Silvio
    Cappello, Maria
    Castiglione, Fabiana
    Orlando, Ambrogio
    GASTROENTEROLOGY, 2010, 138 (05) : S688 - S688
  • [46] Understanding the Cause of Weight Gain in Patients With IBD on Anti-TNF Medications
    Winter, Rachel W.
    Friedman, Sonia
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (01) : 132 - 133
  • [47] Anti-TNF agent drug survival in patients with IBD: real-world comparisons of individual anti-TNF agents based on the Swedish National Quality Registry for IBD (SWIBREG)
    Visuri, I.
    Eriksson, C.
    Mardberg, E.
    Grip, O.
    Gustavsson, A.
    Hjortswang, H.
    Karling, P.
    Montgomery, S.
    Myrelid, P.
    Olen, O.
    Ludvigsson, J. F.
    Halfvarson, J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S443 - S444
  • [48] Vedolizumab-induced endoscopic remission in anti-TNF exposed and anti-TNF naive IBD patients: a large single-centre experience
    Verstockt, B.
    Mertens, E.
    Outtier, A.
    Van Assche, G.
    Vermeire, S.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S47 - S48
  • [49] Outcomes in IBD Patients Who Are Exposed to a Subsequent Anti-TNF Agent Following Anti-TNF Drug Induced Lupus-Like Reaction
    Venu, Mukund
    Dodda, Amar
    Gonzaga, Jason E.
    Naik, Amar S.
    Venu, Nanda
    Perera, Lilani P.
    Stein, Daniel
    GASTROENTEROLOGY, 2013, 144 (05) : S409 - S409
  • [50] Anti-TNF is safe to stop in the second trimester of pregnancy in IBD women in remission
    de Lima, A.
    Zelinkova, Z.
    van der Ent, C.
    van der Woude, C. J.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S301 - S301
12345